EEBR induces Caspase‐1‐dependent pyroptosis through the NF‐κB / NLRP3 signalling cascade in non‐small cell lung cancer
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Xin Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, CAMS Innovation Fund for Medical Sciences (CIFMS), Postdoctoral Research Initiation Fund.
Abstract (Originalsprache)
Lung cancer is a leading cause of cancer‐related deaths worldwide. Recent studies have identified pyroptosis, a type of programmed cell death, as a critical process in the development and progression of lung cancer. In this study, we investigated the effect of EEBR, a new compound synthesized by our team, on pyroptosis in non‐small cell lung cancer cells (NSCLC) and the underlying molecular mechanisms. Our results demonstrated that EEBR significantly reduced the proliferation and metastasis of NSCLC cells in vitro. Moreover, EEBR‐induced pyroptosis in NSCLC cells, as evidenced by cell membrane rupture, the release of cytokines such as interleukin‐18 and interleukin‐1 beta and the promotion of Gasdermin D cleavage in a Caspase‐1‐dependent manner. Furthermore, EEBR promoted the nuclear translocation of NF‐κB and upregulated the protein level of NLRP3. Subsequent studies revealed that EEBR‐induced pyroptosis was suppressed by the inhibition of NF‐κB. Finally, EEBR effectively suppressed the growth of lung cancer xenograft tumours by promoting NSCLC pyroptosis in animal models. Taken together, our findings suggest that EEBR induces Caspase‐1‐dependent pyroptosis through the NF‐κB/NLRP3 signalling cascade in NSCLC, highlighting its potential as a candidate drug for NSCLC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical Universi…
- National Key Laboratory of Frigid Zone Cardiovascular Diseases (NKLFZCD), Harbin, China.
- Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, China.
- Research Unit of Noninfectious Chronic Diseases in Frigid Zone, 2019RU070, Chinese Academy of Medical Sciences, Harbin, China.
ORCID-Profile: Xin Zhao
Förderung
- Natural Science Foundation of Heilongjiang Province
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- Postdoctoral Research Initiation Fund
Zitieren
APA
Zhao, X., Chen, C., Han, W., Liang, M., Cheng, Y., Chen, Y., Pang, D., Lei, H., Feng, X., Cao, S., Li, Z., Wang, J., Zhang, Y., & Yang, B. (2024). EEBR induces Caspase‐1‐dependent pyroptosis through the NF‐κB / NLRP3 signalling cascade in non‐small cell lung cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18094
Vancouver
Zhao X, Chen C, Han W, Liang M, Cheng Y, Chen Y, et al. EEBR induces Caspase‐1‐dependent pyroptosis through the NF‐κB / NLRP3 signalling cascade in non‐small cell lung cancer. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18094
BibTeX
@article{Zhao2024,
author = {Zhao, Xin and Chen, Chao and Han, Weina and Liang, Min and Cheng, Yuanyuan and Chen, Yingjie and Pang, Defeng and Lei, Haoqi and Feng, Xuefei and Cao, Shifeng and Li, Zhixiong and Wang, Jinhui and Zhang, Yan and Yang, Baofeng},
title = {EEBR induces Caspase‐1‐dependent pyroptosis through the NF‐κB / NLRP3 signalling cascade in non‐small cell lung cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18094}
}
EUVIMED